🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
11.87
-0.63 (-5.04%)
At close: Nov 20, 2026, 4:00 PM EST
11.81
-0.06 (-0.51%)
After-hours: Nov 20, 2026, 7:30 PM EST

Omada Health Statistics

Total Valuation

Omada Health has a market cap or net worth of $736.39 million. The enterprise value is $493.24 million.

Market Cap736.39M
Enterprise Value 493.24M

Important Dates

The last earnings date was Thursday, November 5, 2026, after market close.

Earnings Date Nov 5, 2026
Ex-Dividend Date n/a

Share Statistics

Omada Health has 62.04 million shares outstanding. The number of shares has increased by 161.89% in one year.

Current Share Class 62.04M
Shares Outstanding 62.04M
Shares Change (YoY) +161.89%
Shares Change (QoQ) +4.96%
Owned by Insiders (%) 2.46%
Owned by Institutions (%) 91.69%
Float 56.19M

Valuation Ratios

The trailing PE ratio is 52.63 and the forward PE ratio is 17.29.

PE Ratio 52.63
Forward PE 17.29
PS Ratio 2.21
Forward PS 1.87
PB Ratio 2.69
P/TBV Ratio 2.85
P/FCF Ratio 26.16
P/OCF Ratio 25.67
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 37.69, with an EV/FCF ratio of 17.52.

EV / Earnings 35.15
EV / Sales 1.48
EV / EBITDA 37.69
EV / EBIT 71.81
EV / FCF 17.52

Financial Position

The company has a current ratio of 4.18, with zero debt.

Current Ratio 4.18
Quick Ratio 3.88
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 22.37

Financial Efficiency

Return on equity (ROE) is 5.72% and return on invested capital (ROIC) is 1.75%.

Return on Equity (ROE) 5.72%
Return on Assets (ROA) 1.35%
Return on Invested Capital (ROIC) 1.75%
Return on Capital Employed (ROCE) 2.51%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee $339,832
Profits Per Employee $14,320
Employee Count980
Asset Turnover 1.05
Inventory Turnover 24.32

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -37.89% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -37.89%
50-Day Moving Average 18.47
200-Day Moving Average 17.70
Relative Strength Index (RSI) 22.56
Average Volume (20 Days) 1,414,556

Short Selling Information

The latest short interest is 9.16 million, so 14.77% of the outstanding shares have been sold short.

Short Interest 9.16M
Short Previous Month 8.35M
Short % of Shares Out 14.77%
Short % of Float 16.31%
Short Ratio (days to cover) 8.32

Income Statement

In the last 12 months, Omada Health had revenue of $333.04 million and earned $14.03 million in profits. Earnings per share was $0.23.

Revenue333.04M
Gross Profit 235.42M
Operating Income 6.87M
Pretax Income 14.03M
Net Income 14.03M
EBITDA 13.09M
EBIT 6.87M
Earnings Per Share (EPS) $0.23
Full Income Statement

Balance Sheet

The company has $243.15 million in cash and no debt, with a net cash position of $243.15 million or $3.92 per share.

Cash & Cash Equivalents 243.15M
Total Debt n/a
Net Cash 243.15M
Net Cash Per Share $3.92
Equity (Book Value) 273.16M
Book Value Per Share 4.41
Working Capital 239.68M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $28.69 million and capital expenditures -$541,000, giving a free cash flow of $28.15 million.

Operating Cash Flow 28.69M
Capital Expenditures -541,000
Depreciation & Amortization 6.22M
Net Borrowing n/a
Free Cash Flow 28.15M
FCF Per Share $0.45
Full Cash Flow Statement

Margins

Gross margin is 70.69%, with operating and profit margins of 2.06% and 4.21%.

Gross Margin 70.69%
Operating Margin 2.06%
Pretax Margin 4.21%
Profit Margin 4.21%
EBITDA Margin 3.93%
EBIT Margin 2.06%
FCF Margin 8.45%

Dividends & Yields

Omada Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -161.89%
Shareholder Yield -161.89%
Earnings Yield 1.90%
FCF Yield 3.82%

Analyst Forecast

The average price target for Omada Health is $26.50, which is 123.25% higher than the current price. The consensus rating is "Buy".

Price Target $26.50
Price Target Difference 123.25%
Analyst Consensus Buy
Analyst Count 12
Revenue Growth Forecast (3Y) 23.24%
EPS Growth Forecast (3Y) 84.56%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Omada Health has an Altman Z-Score of 8.56 and a Piotroski F-Score of 6.

Altman Z-Score 8.56
Piotroski F-Score 6